Integer Holdings Corporation (NYSE:ITGR) Receives Consensus Recommendation of “Hold” from Brokerages

Integer Holdings Corporation (NYSE:ITGR) has received a consensus recommendation of “Hold” from the eleven brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $98.7143.

ITGR has been the topic of several recent research reports. Truist Financial lifted their price objective on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Piper Sandler reaffirmed an “overweight” rating and issued a $97.00 price objective (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Citigroup lifted their price objective on shares of Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a research note on Thursday, May 28th. Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Finally, Zacks Research downgraded shares of Integer from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th.

Integer Stock Performance

Shares of ITGR opened at $92.81 on Friday. The firm’s 50 day moving average is $87.77 and its 200-day moving average is $83.23. The stock has a market capitalization of $3.15 billion, a P/E ratio of 23.14, a P/E/G ratio of 2.17 and a beta of 0.66. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. Integer has a 12-month low of $62.00 and a 12-month high of $123.78.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). The business had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities research analysts anticipate that Integer will post 6.04 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In other news, VP Tommy P. Thomas sold 825 shares of Integer stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the transaction, the vice president directly owned 4,381 shares of the company’s stock, valued at $372,385. This trade represents a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ITGR. William Blair Investment Management LLC bought a new stake in Integer in the third quarter worth approximately $28,459,000. Public Sector Pension Investment Board grew its position in Integer by 14.9% in the third quarter. Public Sector Pension Investment Board now owns 136,632 shares of the medical equipment provider’s stock worth $14,118,000 after acquiring an additional 17,699 shares in the last quarter. Magnetar Financial LLC bought a new stake in Integer in the third quarter worth approximately $1,890,000. Tudor Investment Corp ET AL grew its position in Integer by 50,787.5% in the third quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after acquiring an additional 29,442,029 shares in the last quarter. Finally, Jennison Associates LLC bought a new stake in Integer in the fourth quarter worth approximately $1,036,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.